Eli Lilly and Company (LLY)

Add a New Bears Reason Company: Eli Lilly and Company (LLY) Current price: Headline: (100 character max) Analysis: Cancel 26% agree 15 votes   Zyprexa will lose patent protection in 2011 Top Contributor: Kryssia Uraguchi | Created when NYSE:LLY was $57.75 | Edit | History Lilly's most lucrative drug, Zyprexa, will lose patent protection by 2011, which makes Lilly's revenue streams very uncertain. (100 character max) Cancel 37% agree 37 votes   Zyprexa causes Diabetes Top Contributor: Will Shikani | Created when NYSE:LLY was $30.43 | Edit | History Lilly has paid over $1 billion in settlements to patients suing over inadequate warnings that Zyprexa causes diabetes and weight gain. The company's efforts to limit the damages has thus far failed, and they stand to lose much more over the coming year. [1] (100 character max) Cancel

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.